Front. Immunol.
Frontiers in Immunology
Front. Immunol.
1664-3224
Frontiers Media S.A.
10.3389/fimmu.2021.700716
Immunology
Correction
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
Choreño-Parra
Jose Alberto
1
2
Jiménez-Álvarez
Luis Armando
2
Ramírez-Martínez
Gustavo
2
Sandoval-Vega
Montserrat
3
Salinas-Lara
Citlaltepetl
4
Sánchez-Garibay
Carlos
4
Luna-Rivero
Cesar
5
Hernández-Montiel
Erika Mariana
2
6
Fernández-López
Luis Alejandro
1
2
Cabrera-Cornejo
María Fernanda
2
6
Choreño-Parra
Eduardo Misael
7
Cruz-Lagunas
Alfredo
2
Domínguez
Andrea
2
6
Márquez-García
Eduardo
2
Cabello-Gutiérrez
Carlos
8
Bolaños-Morales
Francina Valezka
9
Mena-Hernández
Lourdes
10
Delgado-Zaldivar
Diego
10
Rebolledo-García
Daniel
10
Guadarrama-Ortiz
Parménides
11
Regino-Zamarripa
Nora E.
1
2
6
Mendoza-Milla
Criselda
12
García-Latorre
Ethel A.
1
Rodríguez-Reyna
Tatiana Sofía
13
Cervántes-Rosete
Diana
13
Hernández-Cárdenas
Carmen M.
14
Khader
Shabaana A.
15
Zlotnik
Albert
16
Zúñiga
Joaquín
2
6
*
1
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico
2
Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
3
Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Mexico City, Mexico
4
Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suarez”, Mexico City, Mexico
5
Department of Pathology, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
6
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico
7
Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico
8
Department of Virology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
9
Subdirection of Surgery, Instituto Nacional deEnfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
10
Departments of Dermatology and Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
11
Centro Especializado en Neurocirugía y Neurociencias México (CENNM), Mexico City, Mexico
12
Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico
13
Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
14
Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
15
Department of Molecular Microbiology, Washington University School of Medicine in St Louis, St. Louis, MO, United States
16
Department of Physiology & Biophysics School of Medicine, Institute for Immunology, University of California, Irvine, CA, United States
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Joaquín Zúñiga, joazu@yahoo.com
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
13
05
2021
2021
12
700716
26
04
2021
27
04
2021
Copyright © 2021 Choreño-Parra, Jiménez-Álvarez, Ramírez-Martínez, Sandoval-Vega, Salinas-Lara, Sánchez-Garibay, Luna-Rivero, Hernández-Montiel, Fernández-López, Cabrera-Cornejo, Choreño-Parra, Cruz-Lagunas, Domínguez, Márquez-García, Cabello-Gutiérrez, Bolaños-Morales, Mena-Hernández, Delgado-Zaldivar, Rebolledo-García, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, García-Latorre, Rodríguez-Reyna, Cervántes-Rosete, Hernández-Cárdenas, Khader, Zlotnik and Zúñiga
2021
Choreño-Parra, Jiménez-Álvarez, Ramírez-Martínez, Sandoval-Vega, Salinas-Lara, Sánchez-Garibay, Luna-Rivero, Hernández-Montiel, Fernández-López, Cabrera-Cornejo, Choreño-Parra, Cruz-Lagunas, Domínguez, Márquez-García, Cabello-Gutiérrez, Bolaños-Morales, Mena-Hernández, Delgado-Zaldivar, Rebolledo-García, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, García-Latorre, Rodríguez-Reyna, Cervántes-Rosete, Hernández-Cárdenas, Khader, Zlotnik and Zúñiga
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome By Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Sandoval-Vega M, Salinas-Lara C, Sánchez-Garibay C, Luna-Rivero C, Hernández-Montiel EM, Fernández-López LA, Cabrera-Cornejo MF, Choreño-Parra EM, Cruz-Lagunas A, Domínguez A, Márquez-García E, Cabello-Gutiérrez C, Bolaños-Morales FV, Mena-Hernández L, Delgado-Zaldivar D, Rebolledo-García D, Guadarrama-Ortiz P, Regino-Zamarripa NE, Mendoza-Milla C, García-Latorre EA, Rodríguez-Reyna TS, Cervántes-Rosete D, Hernández Cárdenas CM, Khader SA, Zlotnik A and Zúñiga J (2021). Front. Immunol. 12:633297. doi: 10.3389/fimmu.2021.633297.
influenza A(H1N1)
SARS-CoV-2
COVID-19
tuberculosis
chemokines
CXCL17
An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofía Rodríguez-Reyna.
In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.